USA Valsartan Drug Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Valsartan (trade name Diovan, Lupin International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Valsartan Drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Valsartan Drug market. Detailed analysis of key players, along with key growth strategies adopted by Valsartan Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Lupin

    • Novartis

    • Macleods Pharmaceuticals

    • Aurobindo Pharma

    • Square Pharmaceuticals

    • HETERO

    • Sun Pharmaceutical

    • Unichem Laboratories

    • Amneal Pharmaceuticals

    • Alembic Pharmaceuticals

    • Torrent Pharmaceuticals

    • Teva

    • Jubilant Pharma

    • Zhejiang Huahai Pharmaceutical

    • Mylan

    • Huaren Pharmaceutical

    By Type:

    • 40 mg Tablets

    • 80 mg Tablets

    • 160 mg Tablets

    • 320 mg Tablets

    By End-User:

    • Hypertension

    • Heart Failure

    • Heart Attack

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Valsartan Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Valsartan Drug Market Size and Growth Rate of 40 mg Tablets from 2016 to 2027

      • 1.3.2 USA Valsartan Drug Market Size and Growth Rate of 80 mg Tablets from 2016 to 2027

      • 1.3.3 USA Valsartan Drug Market Size and Growth Rate of 160 mg Tablets from 2016 to 2027

      • 1.3.4 USA Valsartan Drug Market Size and Growth Rate of 320 mg Tablets from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Valsartan Drug Market Size and Growth Rate of Hypertension from 2016 to 2027

      • 1.4.2 USA Valsartan Drug Market Size and Growth Rate of Heart Failure from 2016 to 2027

      • 1.4.3 USA Valsartan Drug Market Size and Growth Rate of Heart Attack from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Valsartan Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Valsartan Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Valsartan Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Valsartan Drug Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Valsartan Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Valsartan Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of 40 mg Tablets

      • 3.4.2 Market Size and Growth Rate of 80 mg Tablets

      • 3.4.3 Market Size and Growth Rate of 160 mg Tablets

      • 3.4.4 Market Size and Growth Rate of 320 mg Tablets

    4 Segmentation of Valsartan Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Valsartan Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Valsartan Drug in Hypertension

      • 4.4.2 Market Size and Growth Rate of Valsartan Drug in Heart Failure

      • 4.4.3 Market Size and Growth Rate of Valsartan Drug in Heart Attack

    5 Market Analysis by Regions

    • 5.1 USA Valsartan Drug Production Analysis by Regions

    • 5.2 USA Valsartan Drug Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Valsartan Drug Landscape Analysis

    • 6.1 West USA Valsartan Drug Landscape Analysis by Major Types

    • 6.2 West USA Valsartan Drug Landscape Analysis by Major End-Users

    7 South USA Valsartan Drug Landscape Analysis

    • 7.1 South USA Valsartan Drug Landscape Analysis by Major Types

    • 7.2 South USA Valsartan Drug Landscape Analysis by Major End-Users

    8 Middle West USA Valsartan Drug Landscape Analysis

    • 8.1 Middle West USA Valsartan Drug Landscape Analysis by Major Types

    • 8.2 Middle West USA Valsartan Drug Landscape Analysis by Major End-Users

    9 Northeast USA Valsartan Drug Landscape Analysis

    • 9.1 Northeast USA Valsartan Drug Landscape Analysis by Major Types

    • 9.2 Northeast USA Valsartan Drug Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Lupin

        • 10.1.1 Lupin Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Novartis

        • 10.2.1 Novartis Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Macleods Pharmaceuticals

        • 10.3.1 Macleods Pharmaceuticals Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Aurobindo Pharma

        • 10.4.1 Aurobindo Pharma Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Square Pharmaceuticals

        • 10.5.1 Square Pharmaceuticals Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 HETERO

        • 10.6.1 HETERO Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Sun Pharmaceutical

        • 10.7.1 Sun Pharmaceutical Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Unichem Laboratories

        • 10.8.1 Unichem Laboratories Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Amneal Pharmaceuticals

        • 10.9.1 Amneal Pharmaceuticals Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Alembic Pharmaceuticals

        • 10.10.1 Alembic Pharmaceuticals Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Torrent Pharmaceuticals

        • 10.11.1 Torrent Pharmaceuticals Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Teva

        • 10.12.1 Teva Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Jubilant Pharma

        • 10.13.1 Jubilant Pharma Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

      • 10.14 Zhejiang Huahai Pharmaceutical

        • 10.14.1 Zhejiang Huahai Pharmaceutical Company Profile and Recent Development

        • 10.14.2 Market Performance

        • 10.14.3 Product and Service Introduction

      • 10.15 Mylan

        • 10.15.1 Mylan Company Profile and Recent Development

        • 10.15.2 Market Performance

        • 10.15.3 Product and Service Introduction

      • 10.16 Huaren Pharmaceutical

        • 10.16.1 Huaren Pharmaceutical Company Profile and Recent Development

        • 10.16.2 Market Performance

        • 10.16.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Valsartan Drug Market Size and Growth Rate of 40 mg Tablets from 2016 to 2027

    • Figure USA Valsartan Drug Market Size and Growth Rate of 80 mg Tablets from 2016 to 2027

    • Figure USA Valsartan Drug Market Size and Growth Rate of 160 mg Tablets from 2016 to 2027

    • Figure USA Valsartan Drug Market Size and Growth Rate of 320 mg Tablets from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Valsartan Drug Market Size and Growth Rate of Hypertension from 2016 to 2027

    • Figure USA Valsartan Drug Market Size and Growth Rate of Heart Failure from 2016 to 2027

    • Figure USA Valsartan Drug Market Size and Growth Rate of Heart Attack from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Valsartan Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Valsartan Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Valsartan Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Valsartan Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Valsartan Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Valsartan Drug

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Valsartan Drug by Different Types from 2016 to 2027

    • Table Consumption Share of Valsartan Drug by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of 40 mg Tablets

    • Figure Market Size and Growth Rate of 80 mg Tablets

    • Figure Market Size and Growth Rate of 160 mg Tablets

    • Figure Market Size and Growth Rate of 320 mg Tablets

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Valsartan Drug by Different End-Users from 2016 to 2027

    • Table Consumption Share of Valsartan Drug by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hypertension

    • Figure Market Size and Growth Rate of Heart Failure

    • Figure Market Size and Growth Rate of Heart Attack

    • Table USA Valsartan Drug Production by Regions

    • Table USA Valsartan Drug Production Share by Regions

    • Figure USA Valsartan Drug Production Share by Regions in 2016

    • Figure USA Valsartan Drug Production Share by Regions in 2021

    • Figure USA Valsartan Drug Production Share by Regions in 2027

    • Table USA Valsartan Drug Consumption by Regions

    • Table USA Valsartan Drug Consumption Share by Regions

    • Figure USA Valsartan Drug Consumption Share by Regions in 2016

    • Figure USA Valsartan Drug Consumption Share by Regions in 2021

    • Figure USA Valsartan Drug Consumption Share by Regions in 2027

    • Table West USA Valsartan Drug Consumption by Types from 2016 to 2027

    • Table West USA Valsartan Drug Consumption Share by Types from 2016 to 2027

    • Figure West USA Valsartan Drug Consumption Share by Types in 2016

    • Figure West USA Valsartan Drug Consumption Share by Types in 2021

    • Figure West USA Valsartan Drug Consumption Share by Types in 2027

    • Table West USA Valsartan Drug Consumption by End-Users from 2016 to 2027

    • Table West USA Valsartan Drug Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Valsartan Drug Consumption Share by End-Users in 2016

    • Figure West USA Valsartan Drug Consumption Share by End-Users in 2021

    • Figure West USA Valsartan Drug Consumption Share by End-Users in 2027

    • Table South USA Valsartan Drug Consumption by Types from 2016 to 2027

    • Table South USA Valsartan Drug Consumption Share by Types from 2016 to 2027

    • Figure South USA Valsartan Drug Consumption Share by Types in 2016

    • Figure South USA Valsartan Drug Consumption Share by Types in 2021

    • Figure South USA Valsartan Drug Consumption Share by Types in 2027

    • Table South USA Valsartan Drug Consumption by End-Users from 2016 to 2027

    • Table South USA Valsartan Drug Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Valsartan Drug Consumption Share by End-Users in 2016

    • Figure South USA Valsartan Drug Consumption Share by End-Users in 2021

    • Figure South USA Valsartan Drug Consumption Share by End-Users in 2027

    • Table Middle West USA Valsartan Drug Consumption by Types from 2016 to 2027

    • Table Middle West USA Valsartan Drug Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Valsartan Drug Consumption Share by Types in 2016

    • Figure Middle West USA Valsartan Drug Consumption Share by Types in 2021

    • Figure Middle West USA Valsartan Drug Consumption Share by Types in 2027

    • Table Middle West USA Valsartan Drug Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Valsartan Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Valsartan Drug Consumption Share by End-Users in 2016

    • Figure Middle West USA Valsartan Drug Consumption Share by End-Users in 2021

    • Figure Middle West USA Valsartan Drug Consumption Share by End-Users in 2027

    • Table Northeast USA Valsartan Drug Consumption by Types from 2016 to 2027

    • Table Northeast USA Valsartan Drug Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Valsartan Drug Consumption Share by Types in 2016

    • Figure Northeast USA Valsartan Drug Consumption Share by Types in 2021

    • Figure Northeast USA Valsartan Drug Consumption Share by Types in 2027

    • Table Northeast USA Valsartan Drug Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Valsartan Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Valsartan Drug Consumption Share by End-Users in 2016

    • Figure Northeast USA Valsartan Drug Consumption Share by End-Users in 2021

    • Figure Northeast USA Valsartan Drug Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Lupin

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin

    • Figure Sales and Growth Rate Analysis of Lupin

    • Figure Revenue and Market Share Analysis of Lupin

    • Table Product and Service Introduction of Lupin

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Macleods Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Macleods Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Macleods Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Macleods Pharmaceuticals

    • Table Product and Service Introduction of Macleods Pharmaceuticals

    • Table Company Profile and Development Status of Aurobindo Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurobindo Pharma

    • Figure Sales and Growth Rate Analysis of Aurobindo Pharma

    • Figure Revenue and Market Share Analysis of Aurobindo Pharma

    • Table Product and Service Introduction of Aurobindo Pharma

    • Table Company Profile and Development Status of Square Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Square Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Square Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Square Pharmaceuticals

    • Table Product and Service Introduction of Square Pharmaceuticals

    • Table Company Profile and Development Status of HETERO

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of HETERO

    • Figure Sales and Growth Rate Analysis of HETERO

    • Figure Revenue and Market Share Analysis of HETERO

    • Table Product and Service Introduction of HETERO

    • Table Company Profile and Development Status of Sun Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical

    • Table Product and Service Introduction of Sun Pharmaceutical

    • Table Company Profile and Development Status of Unichem Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Unichem Laboratories

    • Figure Sales and Growth Rate Analysis of Unichem Laboratories

    • Figure Revenue and Market Share Analysis of Unichem Laboratories

    • Table Product and Service Introduction of Unichem Laboratories

    • Table Company Profile and Development Status of Amneal Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amneal Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Amneal Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Amneal Pharmaceuticals

    • Table Product and Service Introduction of Amneal Pharmaceuticals

    • Table Company Profile and Development Status of Alembic Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alembic Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Alembic Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Alembic Pharmaceuticals

    • Table Product and Service Introduction of Alembic Pharmaceuticals

    • Table Company Profile and Development Status of Torrent Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Torrent Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Torrent Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Torrent Pharmaceuticals

    • Table Product and Service Introduction of Torrent Pharmaceuticals

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Jubilant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Pharma

    • Figure Sales and Growth Rate Analysis of Jubilant Pharma

    • Figure Revenue and Market Share Analysis of Jubilant Pharma

    • Table Product and Service Introduction of Jubilant Pharma

    • Table Company Profile and Development Status of Zhejiang Huahai Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zhejiang Huahai Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Zhejiang Huahai Pharmaceutical

    • Figure Revenue and Market Share Analysis of Zhejiang Huahai Pharmaceutical

    • Table Product and Service Introduction of Zhejiang Huahai Pharmaceutical

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Huaren Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Huaren Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Huaren Pharmaceutical

    • Figure Revenue and Market Share Analysis of Huaren Pharmaceutical

    • Table Product and Service Introduction of Huaren Pharmaceutical


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.